Project Grant DP2NS142714
Award Date
9/20/24
Completion Date
8/31/27
Dollars Obligated
$2.9M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $897,250 federal project grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports a comprehensive research program on the role of biomolecular condensates in neurological diseases. The award period is from May 1, 2025 to April 30, 2033. The research program aims to address key questions regarding the physiological functions of biomolecular condensates,...
This Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, provides $3,018,210 to Baylor College of Medicine under the Aging Research program (CFDA 93.866). The grant funds research to functionally dissect a promising transcriptional regulatory network linked to glutamate excitatory signaling that is downregulated in Alzheimer's disease and enriched for suppressors of neurodegeneration. Researchers will perform genetic manipulations in...
This federal Project Grant award, valued at $129,717.00 and awarded on January 20, 2025 by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of neutrophil heterogeneity and molecular mechanisms in driving amyotrophic lateral sclerosis (ALS). The research aims to identify subpopulations of neutrophils and associated mechanisms...
This federal Project Grant award of $2,307,075, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, supports an ambitious research program at Stanford University focused on defining novel mechanisms of human neurodegenerative diseases and translating those findings into new therapeutic strategies. The key objectives of this grant include: 1) Conducting genome-wide...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
This $3,841,367 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports research to better understand the role of the TBK1 protein kinase and associated autophagy pathways in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The University of California, San Francisco (UCSF) will use advanced stem cell models and proteomics to: 1) identify novel TBK1 substrates and characterize the effects of TBK1 loss on...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $760,207 to the Methodist Hospital Research Institute (HMRI) to conduct a multi-omic integrative analysis of inflammation networks across Alzheimer's disease (AD) and frontotemporal dementia (FTD). The goal is to gain a comprehensive molecular understanding of inflammatory cascades and networks in these neurodegenerative disorders, which may identify novel interventional strategies....
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $236,668.00 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on the impact of the C9ORF72-associated poly (GR) protein on the structure and function of the BAF chromatin remodeling complex. The research aims to...
This federal Project Grant award, totaling $826,742, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research to elucidate the structural and molecular basis of the CHCHD10 protein's aggregation and its role in the pathogenesis of frontotemporal dementia. Key objectives include investigating the atomic-resolution structures of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Case Western Reserve University provides $442,750 to develop synthetic replicas of TDP-43 protein filaments associated with frontotemporal dementia and amyotrophic lateral sclerosis. The goal is to establish in vitro conditions for generating amyloid fibrils with structures identical to brain-derived TDP-43 filaments, which would enable mechanistic studies on disease-relevant aggregation pathways...